These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4081474)

  • 1. Safety of aztreonam and SQ 26,992 in elderly patients with renal insufficiency.
    Sattler FR; Schramm M; Swabb EA
    Rev Infect Dis; 1985; 7 Suppl 4():S622-7. PubMed ID: 4081474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam in the treatment of serious gram-negative infections in the elderly.
    Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic and clinical evaluations of aztreonam monotherapy and aztreonam and ampicillin combination therapy in neonates and premature infants].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Tominaga K
    Jpn J Antibiot; 1990 Mar; 43(3):503-23. PubMed ID: 2374300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of aztreonam in healthy recipients and patients: a review.
    Swabb EA
    Rev Infect Dis; 1985; 7 Suppl 4():S605-12. PubMed ID: 3909317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of aztreonam in elderly male volunteers.
    Creasey WA; Platt TB; Frantz M; Sugerman AA
    Br J Clin Pharmacol; 1985 Feb; 19(2):233-7. PubMed ID: 4039189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
    Fuji R; Hashira S; Tajima T; Meguro H; Abe T; Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M
    Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aztreonam therapy for serious gram-negative infections in children.
    Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
    Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of aztreonam on hemodialysis].
    Nagasaka H; Inagaki O; Nasu M; Nakagawa K; Nishian Y; Hiraoka K; Syono T; Azuma M; Hirabayashi T; Mori H
    Jpn J Antibiot; 1990 Feb; 43(2):345-54. PubMed ID: 2362356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aztreonam in patients with gram-negative infections.
    Janicke DM; Cafarell RF; Parker SW; Apicella MA; Jusko WJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):16-20. PubMed ID: 4039117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of aztreonam in peripheral venous serum, uterine arterial serum and intrapelvic female organs].
    Miyakawa I; Taniyama K; Nagai K; Yamao H; Sendai MV; Kawano K; Mori N
    Jpn J Antibiot; 1985 Dec; 38(12):3687-93. PubMed ID: 3834156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and clinical safety of aztreonam in neonates].
    Azagami S; Isohata E; Oikawa T; Osano M; Shiro H
    Jpn J Antibiot; 1990 Mar; 43(3):405-12. PubMed ID: 2374293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety profile of aztreonam in clinical trials.
    Newman TJ; Dreslinski GR; Tadros SS
    Rev Infect Dis; 1985; 7 Suppl 4():S648-55. PubMed ID: 2934785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with aztreonam in Germany and Austria.
    Stille W; Gillissen J
    Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical evaluation of aztreonam in neonates and premature infants].
    Toyonaga Y; Sugita M; Nakamura H; Kawamura K; Seo K
    Jpn J Antibiot; 1990 Mar; 43(3):425-43. PubMed ID: 2374295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
    Clergeot A; Steru D; Rosset MA; Carbon C
    Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
    Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetics of aztreonam in healthy volunteers and renal failure patients.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    J Chemother; 1989 Jun; 1(3):164-9. PubMed ID: 2795125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.